Medicenna Therapeutics (TSX:MDNA) Price-to-Tangible-Book : 9.25 (As of May. 11, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medicenna Therapeutics Price-to-Tangible-Book?

As of today (2024-05-11), Medicenna Therapeutics's share price is C$2.47. Medicenna Therapeutics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was C$0.27. Hence, Medicenna Therapeutics's Price to Tangible Book Ratio of today is 9.25.

The historical rank and industry rank for Medicenna Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

TSX:MDNA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.34 Med: 5.94 Max: 350
Current: 9.15

During the past 9 years, Medicenna Therapeutics's highest Price to Tangible Book Ratio was 350.00. The lowest was 0.34. And the median was 5.94.

TSX:MDNA's Price-to-Tangible-Book is ranked worse than
86.32% of 1221 companies
in the Biotechnology industry
Industry Median: 2.7 vs TSX:MDNA: 9.15

A closely related ratio is called PB Ratio. As of today, Medicenna Therapeutics's share price is C$2.47. Medicenna Therapeutics's Book Value per Sharefor the quarter that ended in Dec. 2023 was C$0.27. Hence, Medicenna Therapeutics's P/B Ratio of today is 9.22.

Medicenna Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Medicenna Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicenna Therapeutics Price-to-Tangible-Book Chart

Medicenna Therapeutics Annual Data

Trend

Dec15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Get a 7-Day Free Trial

8.54

4.67

7.19

4.42

2.08

Medicenna Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.34	2.08	1.66	1.19	1.57

Competitive Comparison of Medicenna Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Medicenna Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicenna Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medicenna Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Medicenna Therapeutics's Price-to-Tangible-Book falls into.

Medicenna Therapeutics Price-to-Tangible-Book Calculation

Medicenna Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	2.47	/	0.267
	=	9.25

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Medicenna Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Medicenna Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicenna Therapeutics (TSX:MDNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medicenna Therapeutics Corp (TSX:MDNA) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

MDNAF:USA

Address

2 Bloor Street W., 7th Floor, Toronto, ON, CAN, M4W 3E2

Website

https://www.medicenna.com

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.

Medicenna Therapeutics (TSX:MDNA) Headlines

No Headlines